Quiz Ref ID More than 350 000 people experience sudden cardiac death in the United States annually.
1 Randomized clinical trials established the benefit of primary prevention implantable cardioverter-defibrillators (ICDs) among patients with low ejection fraction (EF).
2,3 Timing of ICD implantation is critical as studies have not found a benefit to ICD implantation early after myocardial infarction (MI).
4,5 Guidelines recommend primary prevention ICD implantation in patients with an EF of 35% or lower despite being treated with optimal medical therapy for at least 40 days after an MI.
6